7, Sangdo-ro, Dongjak-gu, Seoul, Korea 06955   Tel : 02)8288-114   Fax : 02)8288-029   CS : 02)8288-114

Copyright © 2015 Bukwang Pharmaceutical Co., Ltd.All Rights Reserved.

  • Facebook Basic Square
  • Google+ Basic Square
NEWS

ProteKt Therapeutics Raises $3.6 Million in Post-incubation Financing

[November 13, 2019]

ProteKt Therapeutics, a biotech company developing new PKR kinase inhibitor based therapies for neurodegenerative diseases including  Alzheimer’s Disease, today announced the signing of a binding agreement for a $ US 3.6 million equity financing round. The financing was co-led by Bukwang Pharmaceutical, Fonds de solidarité FTQ, together with existing investors FutuRx, OrbiMed, Johnson & Johnson Innovation – JJDC, Inc., ...

R&D

ASLAN PHARMACEUTICALS AND BUKWANG PHARMACEUTICAL ESTABLISH A JOINT VE...

[September 30, 2019]

ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology and immunology focused biopharma company, and Bukwang Pharmaceuti...

PRODUCTS
COMPANY

Bukwang Pharmaceutical Co., Ltd. was established on October 17th, 1960 and has since continued to produce excellent medications with the aim of improving global health for the last 55 years. Since Bukwang was listed in the Korea Stock Exchange in 1988, Bukwang is proud to have kept a health...

|    ​Korean    |